(Below N is a link to NCBI taxonomic web page and E link to ESTHER at designed phylum.) > cellular organisms: NE > Bacteria: NE > Proteobacteria: NE > Gammaproteobacteria: NE > Pseudomonadales: NE > Moraxellaceae: NE > Acinetobacter: NE > Acinetobacter calcoaceticus/baumannii complex: NE > Acinetobacter baumannii: NE
Warning: This entry is a compilation of different species or line or strain with more than 90% amino acide identity. You can retrieve all strain data
(Below N is a link to NCBI taxonomic web page and E link to ESTHER at designed phylum.) Acinetobacter baumannii ATCC 19606: N, E.
Acinetobacter baumannii WC-692: N, E.
Acinetobacter baumannii OIFC099: N, E.
Acinetobacter baumannii 1437282: N, E.
Acinetobacter baumannii 348935: N, E.
Acinetobacter baumannii 951631: N, E.
Acinetobacter baumannii ATCC 17978: N, E.
Acinetobacter baumannii AB307-0294: N, E.
Acinetobacter baumannii AB0057: N, E.
Acinetobacter baumannii ACICU: N, E.
Acinetobacter baumannii SDF: N, E.
Acinetobacter baumannii AYE: N, E.
Acinetobacter baumannii 1656-2: N, E.
Acinetobacter baumannii TCDC-AB0715: N, E.
Acinetobacter baumannii ABNIH18: N, E.
Acinetobacter baumannii ABNIH20: N, E.
Acinetobacter baumannii NIPH 2061: N, E.
Acinetobacter baumannii ABNIH17: N, E.
Acinetobacter baumannii ABNIH14: N, E.
Acinetobacter baumannii ABNIH26: N, E.
Acinetobacter baumannii ABNIH7: N, E.
Acinetobacter baumannii ABNIH25: N, E.
Acinetobacter baumannii Naval-2: N, E.
Acinetobacter baumannii NIPH 1362: N, E.
Acinetobacter baumannii WC-A-92: N, E.
Acinetobacter baumannii NIPH 410: N, E.
Acinetobacter baumannii ABNIH22: N, E.
Acinetobacter baumannii ABNIH19: N, E.
Acinetobacter baumannii 6013150: N, E.
Acinetobacter baumannii ANC 4097: N, E.
Acinetobacter baumannii OIFC338: N, E.
Acinetobacter baumannii 6013113: N, E.
Acinetobacter baumannii OIFC087: N, E.
Acinetobacter baumannii NIPH 201: N, E.
Acinetobacter baumannii NIPH 60: N, E.
Acinetobacter baumannii ABNIH10: N, E.
Acinetobacter baumannii NIPH 528: N, E.
Acinetobacter baumannii NIPH 527: N, E.
Acinetobacter baumannii ABNIH4: N, E.
Acinetobacter baumannii NIPH 329: N, E.
Acinetobacter baumannii NIPH 24: N, E.
Acinetobacter baumannii 6014059: N, E.
Acinetobacter baumannii ABNIH11: N, E.
Acinetobacter baumannii WC-348: N, E.
Acinetobacter baumannii NIPH 70: N, E.
Acinetobacter baumannii IS-116: N, E.
Acinetobacter baumannii Naval-57: N, E.
Acinetobacter baumannii OIFC035: N, E.
Acinetobacter baumannii Naval-78: N, E.
Acinetobacter baumannii OIFC065: N, E.
Acinetobacter baumannii ABNIH13: N, E.
Acinetobacter baumannii WC-A-694: N, E.
Acinetobacter baumannii NIPH 290: N, E.
Acinetobacter baumannii Naval-113: N, E.
Acinetobacter baumannii ABNIH15: N, E.
Acinetobacter baumannii NIPH 80: N, E.
Acinetobacter baumannii ABNIH24: N, E.
Acinetobacter baumannii Naval-82: N, E.
Acinetobacter baumannii ABNIH6: N, E.
Acinetobacter baumannii AB210: N, E.
Acinetobacter baumannii Canada BC1: N, E.
Acinetobacter baumannii NIPH 1669: N, E.
Acinetobacter baumannii ABNIH5: N, E.
Acinetobacter baumannii ABNIH23: N, E.
Acinetobacter baumannii NIPH 190: N, E.
Acinetobacter baumannii ABNIH16: N, E.
Acinetobacter baumannii 6112: N, E.
Acinetobacter baumanii BIDMC 57: N, E.
Acinetobacter baumannii 25977_9: N, E.
Acinetobacter baumannii 1571545: N, E.
Acinetobacter baumannii ABNIH3: N, E.
Acinetobacter baumannii 1413735: N, E.
Acinetobacter baumannii ABNIH1: N, E.
Acinetobacter baumannii 1428368: N, E.
Acinetobacter baumannii MDR_MMC4: N, E.
Acinetobacter baumannii 457946: N, E.
Acinetobacter baumannii 1195185_11: N, E.
Acinetobacter baumannii Ab44444: N, E.
Acinetobacter baumannii 146457: N, E.
Acinetobacter baumannii 1000160: N, E.
Acinetobacter baumannii 25253_3: N, E.
Acinetobacter baumannii 1276470-86: N, E.
Acinetobacter baumannii CI78: N, E.
Acinetobacter baumannii 573719: N, E.
Acinetobacter baumannii 136706: N, E.
Acinetobacter baumannii BJAB0715: N, E.
Acinetobacter baumannii 44467_5: N, E.
Acinetobacter baumannii ATCC 19606 = CIP 70.34 = JCM 6841: N, E.
Acinetobacter baumannii MDR-ZJ06: N, E.
Acinetobacter baumannii EGD-HP18: N, E.
Acinetobacter baumannii 118362: N, E.
Acinetobacter baumannii 233846: N, E.
Acinetobacter baumannii 625974: N, E.
Acinetobacter baumannii 99063: N, E.
Acinetobacter baumannii NCGM 237: N, E.
Acinetobacter baumannii 15827: N, E.
Acinetobacter baumannii 754286: N, E.
Acinetobacter baumannii 496487: N, E.
Acinetobacter baumannii 855125: N, E.
Acinetobacter baumannii 1295743: N, E.
Acinetobacter baumannii 940793: N, E.
Acinetobacter baumannii NIPH 601: N, E.
Acinetobacter baumannii MRSN 3527: N, E.
Acinetobacter baumannii 21072: N, E.
Acinetobacter baumannii 1419130: N, E.
Acinetobacter baumannii 1288284: N, E.
Acinetobacter baumannii 1451147: N, E.
Acinetobacter sp. SH024: N, E.
Acinetobacter calcoaceticus PHEA-2: N, E.
LegendThis sequence has been compared to family alignement (MSA) red => minority aminoacid blue => majority aminoacid color intensity => conservation rate title => sequence position(MSA position)aminoacid rate Catalytic site Catalytic site in the MSA MNKPQYNMFCLPPAGSSASIYHPWKKQISDNIRIIPIEYSGHGIKINEPL IDDPDLLAMQIANEIQAYSDTPFILFGHSVGGSLIWKVLNYLNEKTIIDQ LRLIVISSRPEHHYIQHMRYKHELTDEKIIDELKRYNNFPDEILNNQDAL TFFLKIIRNDLYLSDQLLGEKIHKTEVPIVAFYGKQDPDIPNKRMMDAWQ QHTENWLGSIEFEGDHFYFLNPETRVKMLENIAAIVETLTVNIE
The recent emergence of multidrug resistance (MDR) in Acinetobacter baumannii has raised concern in health care settings worldwide. In order to understand the repertoire of resistance determinants and their organization and origins, we compared the genome sequences of three MDR and three drug-susceptible A. baumannii isolates. The entire MDR phenotype can be explained by the acquisition of discrete resistance determinants distributed throughout the genome. A comparison of closely related MDR and drug-susceptible isolates suggests that drug efflux may be a less significant contributor to resistance to certain classes of antibiotics than inactivation enzymes are. A resistance island with a variable composition of resistance determinants interspersed with transposons, integrons, and other mobile genetic elements is a significant but not universal contributor to the MDR phenotype. Four hundred seventy-five genes are shared among all six clinical isolates but absent from the related environmental species Acinetobacter baylyi ADP1. These genes are enriched for transcription factors and transporters and suggest physiological features of A. baumannii that are related to adaptation for growth in association with humans.
The whole-genome sequence of an epidemic, multidrug-resistant Acinetobacter baumannii strain (strain ACICU) belonging to the European clone II group and carrying the plasmid-mediated bla(OXA)(-)(58) carbapenem resistance gene was determined. The A. baumannii ACICU genome was compared with the genomes of A. baumannii ATCC 17978 and Acinetobacter baylyi ADP1, with the aim of identifying novel genes related to virulence and drug resistance. A. baumannii ACICU has a single chromosome of 3,904,116 bp (which is predicted to contain 3,758 genes) and two plasmids, pACICU1 and pACICU2, of 28,279 and 64,366 bp, respectively. Genome comparison showed 86.4% synteny with A. baumannii ATCC 17978 and 14.8% synteny with A. baylyi ADP1. A conspicuous number of transporters belonging to different superfamilies was predicted for A. baumannii ACICU. The relative number of transporters was much higher in ACICU than in ATCC 17978 and ADP1 (76.2, 57.2, and 62.5 transporters per Mb of genome, respectively). An antibiotic resistance island, AbaR2, was identified in ACICU and had plausibly evolved by reductive evolution from the AbaR1 island previously described in multiresistant strain A. baumannii AYE. Moreover, 36 putative alien islands (pAs) were detected in the ACICU genome; 24 of these had previously been described in the ATCC 17978 genome, 4 are proposed here for the first time and are present in both ATCC 17978 and ACICU, and 8 are unique to the ACICU genome. Fifteen of the pAs in the ACICU genome encode genes related to drug resistance, including membrane transporters and ex novo acquired resistance genes. These findings provide novel insight into the genetic basis of A. baumannii resistance.
        
Title: Identification and transcriptional organization of a gene cluster involved in biosynthesis and transport of acinetobactin, a siderophore produced by Acinetobacter baumannii ATCC 19606T Mihara K, Tanabe T, Yamakawa Y, Funahashi T, Nakao H, Narimatsu S, Yamamoto S Ref: Microbiology, 150:2587, 2004 : PubMed
In order to assimilate iron, Acinetobacter baumannii ATCC 19606(T) produces a siderophore named acinetobactin (Ab) that is composed of equimolar quantities of 2,3-dihydroxybenzoic acid (DHBA), L-threonine and N-hydroxyhistamine. Application of the Fur titration assay system to A. baumannii genomic libraries, followed by further cloning of the regions surrounding the candidate genes, led to the identification of the Ab cluster, which harbours the genetic determinants necessary for the biosynthesis and transport of the siderophore. However, an entA homologue essential for DHBA biosynthesis was not found in this cluster. Functions of potential biosynthetic genes inferred by homology studies suggested that the precursors, DHBA, l-threonine and N-hydroxyhistamine, are linked in steps resembling those of bacterial non-ribosomal peptide synthesis to form Ab. Genes responsible for the two-step biosynthesis of N-hydroxyhistamine from histidine were also identified in this cluster. Their genetic organization suggests that five genes involved in the transport system of ferric Ab into the cell cytosol form an operon. Construction of disruptants of some selected genes followed by phenotypic analysis supported their predicted biological functions. Interestingly, three additional genes probably involved in the intracellular release of iron from ferric Ab and the secretion of nascent Ab are contained in this cluster. Primer extension and RT-PCR analyses suggested that the Ab cluster, which includes 18 genes, is organized in seven transcriptional units originating from respective Fur-regulated promoter-operator regions.
Acinetobacter baumannii has emerged as a significant nosocomial pathogen worldwide. The increasing trend of carbapenem and fluoroquinolone resistance in A. baumannii severely limits the usage of therapeutic antimicrobial agents. Here we report the genome sequence of a multidrug-resistant A. baumannii strain, TCDC-AB0715, harboring both bla(OXA-23) and bla(OXA-66).
Genome analysis of Acinetobacter calcoaceticus PHEA-2 was undertaken because of the importance of this bacterium for bioremediation of phenol-polluted water and because of the close phylogenetic relationship of this species with the human pathogen Acinetobacter baumannii. To our knowledge, this is the first strain of A. calcoaceticus whose genome has been sequenced.
The recent emergence of multidrug resistance (MDR) in Acinetobacter baumannii has raised concern in health care settings worldwide. In order to understand the repertoire of resistance determinants and their organization and origins, we compared the genome sequences of three MDR and three drug-susceptible A. baumannii isolates. The entire MDR phenotype can be explained by the acquisition of discrete resistance determinants distributed throughout the genome. A comparison of closely related MDR and drug-susceptible isolates suggests that drug efflux may be a less significant contributor to resistance to certain classes of antibiotics than inactivation enzymes are. A resistance island with a variable composition of resistance determinants interspersed with transposons, integrons, and other mobile genetic elements is a significant but not universal contributor to the MDR phenotype. Four hundred seventy-five genes are shared among all six clinical isolates but absent from the related environmental species Acinetobacter baylyi ADP1. These genes are enriched for transcription factors and transporters and suggest physiological features of A. baumannii that are related to adaptation for growth in association with humans.
The whole-genome sequence of an epidemic, multidrug-resistant Acinetobacter baumannii strain (strain ACICU) belonging to the European clone II group and carrying the plasmid-mediated bla(OXA)(-)(58) carbapenem resistance gene was determined. The A. baumannii ACICU genome was compared with the genomes of A. baumannii ATCC 17978 and Acinetobacter baylyi ADP1, with the aim of identifying novel genes related to virulence and drug resistance. A. baumannii ACICU has a single chromosome of 3,904,116 bp (which is predicted to contain 3,758 genes) and two plasmids, pACICU1 and pACICU2, of 28,279 and 64,366 bp, respectively. Genome comparison showed 86.4% synteny with A. baumannii ATCC 17978 and 14.8% synteny with A. baylyi ADP1. A conspicuous number of transporters belonging to different superfamilies was predicted for A. baumannii ACICU. The relative number of transporters was much higher in ACICU than in ATCC 17978 and ADP1 (76.2, 57.2, and 62.5 transporters per Mb of genome, respectively). An antibiotic resistance island, AbaR2, was identified in ACICU and had plausibly evolved by reductive evolution from the AbaR1 island previously described in multiresistant strain A. baumannii AYE. Moreover, 36 putative alien islands (pAs) were detected in the ACICU genome; 24 of these had previously been described in the ATCC 17978 genome, 4 are proposed here for the first time and are present in both ATCC 17978 and ACICU, and 8 are unique to the ACICU genome. Fifteen of the pAs in the ACICU genome encode genes related to drug resistance, including membrane transporters and ex novo acquired resistance genes. These findings provide novel insight into the genetic basis of A. baumannii resistance.
Acinetobacter baumannii has emerged as an important and problematic human pathogen as it is the causative agent of several types of infections including pneumonia, meningitis, septicemia, and urinary tract infections. We explored the pathogenic content of this harmful pathogen using a combination of DNA sequencing and insertional mutagenesis. The genome of this organism was sequenced using a strategy involving high-density pyrosequencing, a novel, rapid method of high-throughput sequencing. Excluding the rDNA repeats, the assembled genome is 3,976,746 base pairs (bp) and has 3830 ORFs. A significant fraction of ORFs (17.2%) are located in 28 putative alien islands, indicating that the genome has acquired a large amount of foreign DNA. Consistent with its role in pathogenesis, a remarkable number of the islands (16) contain genes implicated in virulence, indicating the organism devotes a considerable portion of its genes to pathogenesis. The largest island contains elements homologous to the Legionella/Coxiella Type IV secretion apparatus. Type IV secretion systems have been demonstrated to be important for virulence in other organisms and thus are likely to help mediate pathogenesis of A. baumannii. Insertional mutagenesis generated avirulent isolates of A. baumannii and verified that six of the islands contain virulence genes, including two novel islands containing genes that lacked homology with others in the databases. The DNA sequencing approach described in this study allows the rapid elucidation of the DNA sequence of any microbe and, when combined with genetic screens, can identify many novel genes important for microbial pathogenesis.
        
Title: Identification and transcriptional organization of a gene cluster involved in biosynthesis and transport of acinetobactin, a siderophore produced by Acinetobacter baumannii ATCC 19606T Mihara K, Tanabe T, Yamakawa Y, Funahashi T, Nakao H, Narimatsu S, Yamamoto S Ref: Microbiology, 150:2587, 2004 : PubMed
In order to assimilate iron, Acinetobacter baumannii ATCC 19606(T) produces a siderophore named acinetobactin (Ab) that is composed of equimolar quantities of 2,3-dihydroxybenzoic acid (DHBA), L-threonine and N-hydroxyhistamine. Application of the Fur titration assay system to A. baumannii genomic libraries, followed by further cloning of the regions surrounding the candidate genes, led to the identification of the Ab cluster, which harbours the genetic determinants necessary for the biosynthesis and transport of the siderophore. However, an entA homologue essential for DHBA biosynthesis was not found in this cluster. Functions of potential biosynthetic genes inferred by homology studies suggested that the precursors, DHBA, l-threonine and N-hydroxyhistamine, are linked in steps resembling those of bacterial non-ribosomal peptide synthesis to form Ab. Genes responsible for the two-step biosynthesis of N-hydroxyhistamine from histidine were also identified in this cluster. Their genetic organization suggests that five genes involved in the transport system of ferric Ab into the cell cytosol form an operon. Construction of disruptants of some selected genes followed by phenotypic analysis supported their predicted biological functions. Interestingly, three additional genes probably involved in the intracellular release of iron from ferric Ab and the secretion of nascent Ab are contained in this cluster. Primer extension and RT-PCR analyses suggested that the Ab cluster, which includes 18 genes, is organized in seven transcriptional units originating from respective Fur-regulated promoter-operator regions.